Article
Warfarin Dosing According to the Genotype-guided Algorithm is Most Beneficial in Patients With Atrial Fibrillation: A Randomized Parallel Group Trial.
Therapeutic drug monitoring - 1 Jun 2018
Makar-Aušperger Ksenija, Krželj Kristina, Lovrić Benčić Martina, Radačić Aumiler Matea, Erdeljić Turk Viktorija, Božina Nada
Abstract excerpt
BACKGROUND: Observational studies have indicated potential benefits of CYP2C9- and VKORC1-guided dosing of warfarin but randomized clinical trials have resulted in contradictory findings. One of the reasons for contradiction may be the negligence of possible differences between warfarin indications. This study aims to determine efficacy and safety of genotype-guided and clinically guided dosing of warfarin in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
